Ulrich Mahlknecht
- New
- 31 years of experience
- Location: Germany, Dusseldorf
Prof. Dr. med. Ulrich Mahlknecht, PhD, is a German hematologist and medical oncologist with over 30 years of experience in blood cancers and solid tumors. His focus includes AML, CLL, MDS, lymphomas, gastrointestinal oncology, and palliative care. He also provides second opinions for complex cases.
He served as Chief Physician of Hematology and Oncology in Solingen from 2012 to 2020. He held a W3 professorship and directed the Chair of Immunotherapy and Gene Therapy at Saarland University. He was a senior physician in Heidelberg and led the MDS Center of Excellence and the MDS/Acute Leukemia Task Force. He earned his Dr. med. in 1995 and a PhD from SUNY in 1998. He completed his Habilitation in 2004 and holds USMLE/ECFMG certification.
He has authored about 100 publications, including in The Lancet, Blood, and Leukemia. He has been a principal investigator or investigator in more than 20 leukemia and MDS trials. He founded the journal Clinical Epigenetics (Springer) and served as Editor-in-Chief. He received the Clinical Science Award in 2004 and led a DFG Emmy Noether group. He is board-certified in Internal Medicine, Hematology and Oncology, Gastroenterology, Palliative Medicine, and Nutritional Medicine. He is a member of DGHO, ESMO, ASH, AACR, and DKG. He offers online, written, and in-person consultations in Solingen. Languages: German, English, Italian, French.
- Read more





